The Thriving Black Market for a Powerful Weight Loss Drug

The emergence of a robust black market for potent weight loss medications reflects a critical intersection of high patient demand and persistent supply chain constraints within the pharmaceutical industry. This illicit trade introduces significant risks regarding product safety, dosage accuracy, and the potential for counterfeit formulations entering the consumer market. For pharmaceutical companies, these developments necessitate a focus on protecting intellectual property and ensuring that legitimate therapeutic channels remain the primary source for patient care.